Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL action will tell all sometime.

Also consider, TPL has to burn a lot of cash to pay employees to reverse engineer products, to pay employees to persue licenses, and etc. We split 50% of MMP proceeds with them, their 50% is split 55% to Moore- 45% to TPL(could be the other way -not sure) They have to burn a lot more cash than us. It seems that they took a gamble, didn't pay Moore, used that cash in hopes that the MMP would save them, then had some set backs. The biggest one is that Moore didn't get involved with USPTO process when he wasn't paid and now no USPTO approval yet. Once Moore gets on track to get USPTO approval it could be a whole new ballgame. I think everyone is putting the squeeze on TPL to get them out of the process. I think TPL blew the discovery process in the J's trial and that is why Roger Cooke is no longer lead attorney. Now in the background Moore could be putting the squeeze on us to get us to do what he wants, or expects. If he is still the owner of the patents as he claims, if he doesn't come through then we own half of nothing, same for him. So, although I would like to be enlightened on all of this, if there is indeed this much intrigue, I doubt that I will, until it has played out. Same old story.

We as share-holders need to be enlightened on all of this so we can make some rational decisions. A class action suit is a way to get even without making money-not an option IMO. Just remember-Lawyers got us into this mess, don't pay them to get us out, unless we all make money. Don't let them be vulchers picking over our bones. Be very carefull who you align yourselves with, could be ambulance chasers.

Share
New Message
Please login to post a reply